— Longer Synthetic DNA Accelerates Customer Discoveries — SAN FRANCISCO — Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis on silicon, today announced that it is now shipping genes up to 3,200 base pairs (3.2 kilobase or kB) in length to Ginkgo Bioworks under their existing supply agreement. “Twist Bioscience continues to […]
Alameda, CA – Singulex, Inc. today announced that it has entered into a strategic collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) focused on the development of companion diagnostics. Through the collaboration, QIAGEN will have access to Singulex’s Single Molecule Counting immunodiagnostic platform, adding additional immunoassay capabilities to QIAGEN’s existing molecular testing services […]
MORGANTOWN, W.Va. — Protea Biosciences Group, Inc. (OTCQB:PRGB) (“Protea”) announced today that the Company has entered into a co-marketing agreement with MatTek Corporation (“MatTek”), which allows Protea to include MatTek’s human cell based in vitro tissue models with Protea’s proprietary molecular imaging services. “By combining the human tissue models with mass spectrometry imaging workflows, researchers will be able […]
WASHINGTON, D.C. MINNEAPOLIS, MN – The COPD Foundation-sponsored COPD Biomarker Qualification Consortium (CBQC) today announced that it has partnered with the Bio-Techne Corporation, a manufacturer of biotechnology products for life science research and diagnostics. The partnership was established to evaluate the suitability of a soluble form of receptor for advanced glycation end products (sRAGE) as a predictive biomarker […]
Combines award-winning Chromium™ System from 10x Genomics with PerkinElmer’s state-of-the-art automation solutions PLEASANTON, Calif. – 10x Genomics, Inc., a company focused on enabling the mastery of biology by accelerating genomic discovery, today announced they and PerkinElmer, Inc. will jointly offer automated next-generation sequencing (NGS) solutions. PerkinElmer’s automation solutions increase both the throughput and efficiency of […]
CROMWELL, Conn. & WINDSOR, Conn.–Biological Industries USA, Inc. (BI‐USA) and Rainbow Scientific, Inc. announced today a co‐promotion and sales agreement that grants Rainbow Scientific both promotion and sales rights to BI-USA’s range of cytogenetic products to the clinical laboratory market. “Rainbow Scientific has been a leading distributor to hospital laboratories, medical reference laboratories, and clinical […]
SAN DIEGO & HERCULES, Calif.– Illumina, Inc. (NASDAQ:ILMN) and Bio-Rad Laboratories, Inc. (NYSE:BIO) (NYSE:BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response. […]
Data interpretation from Watson will help users translate genomic data from Illumina TruSight® Tumor 170; offering to be available early in 2017 SAN FRANCISCO – IBM Watson Health (NYSE:IBM) and Illumina, Inc. (NASDAQ:ILMN) today announced a groundbreaking partnership to expand access to genome data interpretation by integrating Watson for Genomics into Illumina’s BaseSpace Sequence Hub and tumor sequencing […]
Collaboration aims to leverage Illumina’s world-class DNA sequencing technology and BaseSpace Sequence Hub with Philips’ innovative cloud-based genomics platform for the acquisition, analysis and interpretation of genomics data in cancer research Amsterdam, the Netherlands, and San Diego, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc.(NASDAQ:ILMN), the global leader in DNA […]
– Effort will sequence the genomes of 45,000 participants from across Ireland to identify novel targets and advance the clinical development of better treatments for a range of serious diseases – Focus is on key AbbVie therapeutic areas including oncology, neuroscience and immunology – Genomics Medicine Ireland will partner with Ireland’s leading clinicians and researchers […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
